Myeloproliferative Neoplasms

章节
出版模式：

开放获取
发表日期：

2024年

查看全文

Nicolaus Kröger,
Donal P. McLornan,
Yves Chalandon

摘要

Polycythemia vera (PV) and essential thrombocythemia (ET) have a favorable outcome without need for allo-HCT unless the disease has progressed to post-ET/PV myelofibrosis or secondary AML (Lussana et al. 2014).